Isoproterenol Hydrochloride Injection, Solution
Product Images NDC 23155-660

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Isoproterenol Hydrochloride (NDC 23155-660). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

0a8d0ebe 47d5 46f1 9c02 D27a637f3db6 01

FDA Label Image

0a8d0ebe 47d5 46f1 9c02 D27a637f3db6 02

FDA Label Image

0a8d0ebe 47d5 46f1 9c02 D27a637f3db6 03

FDA Label Image

0a8d0ebe 47d5 46f1 9c02 D27a637f3db6 04

0a8d0ebe 47d5 46f1 9c02 D27a637f3db6 04
This is a prescription drug called Isoproterenol Hydrochloride Injection manufactured by Avet Pharma. It comes in a 0.2 mg/mL solution and is for intravenous, subcutaneous, intramuscular, or intracardiac use only. The drug is available in 10x 1 mL single dose vials and any unused portion should be discarded. The packaging includes the manufacturer's address and contact information.*
FDA Label Image

0a8d0ebe 47d5 46f1 9c02 D27a637f3db6 05

FDA Label Image

0a8d0ebe 47d5 46f1 9c02 D27a637f3db6 06

0a8d0ebe 47d5 46f1 9c02 D27a637f3db6 06
Isoproterenol is a medication available in injection form, with a concentration of 0.2 mg/mL in Isoproterenol Hydrochloride Injection, USP. It is produced by Avet Pharma and may be used to treat cardiac problems. The text also mentions Fycrocioncenecten, UsP, but it is not clear how this is related to the medication.*
FDA Label Image

0a8d0ebe 47d5 46f1 9c02 D27a637f3db6 07

0a8d0ebe 47d5 46f1 9c02 D27a637f3db6 07
This is a label from a single dose vial of ISOPrOterem injection manufactured by Emcure Pharmaceuticals Ltd. The injection contains 1mg/5mL of ISOPrOterem and can be administered through intravenous, subcutaneous, intramuscular or intracardiac routes. The label provides manufacturing and license details, and advises to protect the injection from light, discard unused portion, and use before the expiration date.*
FDA Label Image

0a8d0ebe 47d5 46f1 9c02 D27a637f3db6 08

FDA Label Image

0a8d0ebe 47d5 46f1 9c02 D27a637f3db6 09

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.